CA Patent
CA2642583C — Boron-containing small molecules as anti-inflammatory agents
Assigned to Anacor Pharmaceuticals LLC · Expires 2016-08-23 · 10y expired
What this patent protects
Use for treating anti-inflammatory conditions of boron-containing small molecules of formula Ia are disclosed: (see formula IA)
USPTO Abstract
Use for treating anti-inflammatory conditions of boron-containing small molecules of formula Ia are disclosed: (see formula IA)
Drugs covered by this patent
- Eucrisa (Crisaborole) · Anacor Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.